PAVmed Provides Business Update and Second Quarter Financial

EsoGuard® test volume continues to grow as Lucid makes strides with commercial expansion and additional supporting data
Veris Health prepares to launch the next generation of the Veris Cancer Care...
-Today at 08:19 pm- MarketScreener

Related Keywords

Lishan Aklog , Gary Manning , Veris Health Inc , Source Pavmed Inc , Veris Health , Satellite Lucid Test Center , Nasdaq , Lucid Diagnostics Inc , Pavmed Inc , Exchange Commission , Veris Cancer Care Platform , Lucid Diagnostics , Chief Executive , Medical Device , Biopharma Companion Digital Platform , Medical Device Data System , Esophageal Cell Collection Device , Veris Cancer Care , Annual Report , Markets ,